We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology Newsfeed
  • Blog
  • Events
  • Popular
  • Awards
  • About
  • Login
  • Register
  • Blog
  • Events
  • Popular
  • Awards
  • About
  • Login
  • Register
  • Newsfeed
  • Navigator
  • Hubs
  • Webinars
  • Store
  • Analytics
  • Insights
  • Track
  • Create
  • My Lexology
  • Newsfeed
  • Navigator
  • Hubs
  • Webinars
  • Store
  • Analytics
  • Insights
  • Track
  • Create
  • My Lexology
Back Forward
  • Save & file
  • View original
  • Forward
  • Share
    • Facebook
    • Twitter
    • Linked In
  • Follow
    Please login to follow content.
  • Like

add to folder:

  • My saved (default)
  • Read later
Folders shared with you

Register now for your free, tailored, daily legal newsfeed service.

Questions? Please contact customerservices@lexology.com

Register

False patent marking: a trap for the unwary patentee

Fitzpatrick, Cella, Harper & Scinto

To view this article you need a PDF viewer such as Adobe Reader. Download Adobe Acrobat Reader

USA January 5 2009
Fitzpatrick, Cella, Harper & Scinto - This article first appeared in IAM magazine. For further information please visit <a target="_blank" href="http://www.iam-magazine.com/">www.iam-magazine.com</a> <br />&nbsp; <br />&nbsp;
Back Forward
  • Save & file
  • View original
  • Forward
  • Share
    • Facebook
    • Twitter
    • Linked In
  • Follow
    Please login to follow content.
  • Like

add to folder:

  • My saved (default)
  • Read later
Folders shared with you

Filed under

  • USA
  • Intellectual Property
  • Litigation
  • Fitzpatrick, Cella, Harper & Scinto

Popular articles from this firm

  1. Amgen Obtains $70 Million Damages Award Against Hospira For Infringement Of Amgen’s Erythropoetin Patent *
  2. Amgen obtains $70 million damages award against Hospira for erythropoietin patent infringement *
  3. Federal Circuit Clarifies Venue Issues In Patent Cases *
  4. Federal Circuit Suggests That “Insubstantial Differences” Test May Be More Suitable Than “Function-Way-Result” Test For Evaluating Equivalence In Chemical Patent Cases *
  5. 'Repeat infringers' under Digital Millennium Copyright Act not repeat infringers as adjudged by court *

If you would like to learn how Lexology can drive your content marketing strategy forward, please email enquiries@lexology.com.

Send to Create
Powered by Lexology

Related topic hubs

  1. USA
  2. Litigation
  3. Intellectual Property

Related USA articles

  1. Issues related to patent marking and false marking in the United States *
  2. Changes to the awarding of fines for false patent marking *
  3. The America Invents Act applies the brakes to the false marking bandwagon *

Related international articles

  1. Foreign patent numbers create false marking risk * - Canada
  2. US patent law reform patent marking * - Australia
  3. New patent marking measures launched * - China

Lexology Navigator Q&A

Compare jurisdictions:Patents

  1. USA
  2. Mexico
  3. Hungary
  4. View more
Hanh T. Pham
Counsel, Intellectual Property
Global Downstream IP Team
What our clients say

"Love the service, really good quality articles in general."

Back to Top
  • Terms of use
  • Cookies
  • Disclaimer
  • Privacy policy
  • GDPR Compliance
  • RSS feeds
  • Contact
  • Submissions
  • About
  • Login
  • Register
  • Follow on Twitter
  • Search
Globe Business Media Group

© Copyright 2006 - 2018 Globe Business Media Group